Loading...
Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumour effects in vivo
Indoleamine 2,3-dioxygenase 1 (IDO1) as a key rate-limiting enzyme in the kynurenine pathway of tryptophan metabolism plays an important role in tumour immune escape. Herein, a variety of secondary sulphonamides were synthesised and evaluated in the HeLa cell-based IDO1/kynurenine assay, leading to...
Saved in:
| Published in: | J Enzyme Inhib Med Chem |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Taylor & Francis
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7336998/ https://ncbi.nlm.nih.gov/pubmed/32466694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2020.1765165 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|